ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for TScan Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:38 am Sale |
2024-12-31 | 13G | TScan Therapeutics, Inc. TCRX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 3,500,000 7.130% |
-400,000 (-10.26%) |
Filing |
| 2024-02-07 07:45 am Sale |
2023-12-31 | 13G | TScan Therapeutics, Inc. TCRX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 3,900,000 8.960% |
-100,000 (-2.50%) |
Filing |
| 2023-06-12 4:30 pm Purchase |
2023-05-31 | 13G | TScan Therapeutics, Inc. TCRX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 4,000,000 9.350% |
4,000,000 (New Position) |
Filing |